Post-Surgical Diabetic with Charcot Foot: Choosing a Device When Insurance Won't Cover the Ideal
A 58-year-old man with type 2 diabetes (HbA1c 9.1%), peripheral neuropathy, and a prior transmetatarsal amputation on the left foot presents 6 weeks after a midfoot Charcot diagnosis. His right foot is the contralateral limb: intact, with a rigid hallux and a bony prominence at the first metatarsal head. He is 118 kg, ambulates with a walker, and has a 2 cm leg-length discrepancy from the amputation. His insurance authorizes a custom-molded depth-inlay shoe and a total-contact insert but denies a CROW (Charcot restraint orthotic walker) as not medically necessary. The referring physician has documented that the midfoot is clinically stable on exam but no imaging has been repeated since diagnosis. The patient wants to return to part-time work as a cashier within 3 weeks, which requires 6-hour standing shifts.
1. Should the orthotist proceed with the authorized depth-inlay shoe and insert, or pursue the denied CROW? Justify your recommendation using the clinical findings, and identify what information is missing before either device is finalized.
Read the worked answer
The authorized depth-inlay shoe plus total-contact insert is not an adequate substitute for a CROW in an acute-to-subacute Charcot foot, even if the foot feels stable on palpation. The key problem is that clinical stability on exam does not equal radiographic or clinical readiness for weight-bearing in a removable device. The CROW's value is circumferential rigid control that offloads the midfoot and limits motion; a depth-inlay shoe with an insert provides accommodation and pressure redistribution but does not restrain the midfoot.
Missing information that must be obtained before finalizing either device:
- Repeat imaging (weight-bearing radiographs or MRI) to confirm consolidation and rule out active inflammation or progression. Six weeks post-diagnosis is often still within the active phase.
- Skin and temperature assessment: compare warmth, erythema, and any ulceration between limbs; a temperature differential suggests active disease.
- Vascular status: pulses, ABI, or toe pressures, since healing capacity affects device tolerance.
- Contralateral limb risk: the right foot has a rigid hallux and a first metatarsal prominence, making it the next at-risk site.
Recommendation: do not clear the patient for 6-hour standing shifts in a depth-inlay shoe. Document the denial and pursue peer-to-peer review or an appeal with the imaging and temperature data. If the CROW remains denied, the fallback is a removable cast walker with strict non-weight-bearing or limited weight-bearing until imaging confirms consolidation, not a return to full shifts. The 3-week return-to-work goal is not clinically defensible regardless of device choice until the midfoot is confirmed stable.
2. Assuming the patient is eventually cleared for protected weight-bearing, how should the 2 cm leg-length discrepancy and the contralateral first metatarsal prominence shape the orthotic prescription?
Read the worked answer
Two separate problems need to be addressed, and they interact.
Leg-length discrepancy (2 cm): A 2 cm discrepancy is large enough to alter gait and load the contralateral limb. With a transmetatarsal amputation, the prosthetic or orthotic build-up must restore level pelvis and symmetric stance. Options: an external shoe lift (full-length or heel-only depending on whether the discrepancy is true or apparent from the amputation), or a built-up sole on the orthotic shoe. A heel-only lift of 2 cm is poorly tolerated; a full-length lift distributes load better. The lift must be integrated with the CROW or depth-inlay shoe so the device does not torque the midfoot. Verify with a standing assessment and, if available, a lift trial.
Contralateral first metatarsal prominence with rigid hallux: This is the highest-risk site for a new ulcer. The insert must include a metatarsal pad proximal to the prominence and a relief or cutout under the first metatarsal head, with a rigid or semi-rigid shell to prevent the foot from sinking into the relief. Do not simply cushion; cushioning alone increases focal pressure. A rocker-bottom sole reduces demand on the first MTP joint during push-off.
Integration: The left (amputated) side needs a filler to fill the shoe toe box and maintain the foot's position, plus the lift. The right side needs the pressure-relief insert. A single pair of mismatched devices is appropriate. Reassess skin at both sites at every visit, and set a follow-up interval of 1-2 weeks initially, not the usual 3 months.